Hem#265 Rar May 2026

Development and Application of a Glucocorticoid/Retinoic Acid Receptor (GR-RAR) Chimera for In Vivo Translocation Assays

The GR-RAR chimera is a powerful tool for discovering novel RAR ligands and analogues. It improves upon standard assays that exclusively measure gene activation potential, as this system visualizes the receptor's subcellular trafficking. This technique offers significant advantages in studies exploring ligand-induced receptor dynamics. 5. Conclusion Hem#265 rar

The chimera is constructed by fusing the ligand-binding domain of the retinoic acid receptor (RAR) to a reporter sequence that allows tracking (e.g., green fluorescent protein). Monitoring the activation of RAR

Upon the introduction of the normal RAR ligand, all-trans-retinoic acid, the chimeric receptor undergoes nuclear translocation. 3. Results: Translocation Tracking including cardiac function and zeaxanthin recovery

The chimeric receptor provides a dramatic and easily monitored visual indicator of RAR ligand presence in the cellular environment.

The Retinoic Acid Receptor (RAR) plays a crucial role in mediating the effects of all-trans-retinoic acid, which regulates cellular differentiation and development. Monitoring the activation of RAR, however, is challenging due to complex subcellular trafficking mechanisms. While retinoic acid receptor alpha (RAR-α) gene expression is associated with significant physiological processes, including cardiac function and zeaxanthin recovery, a direct, real-time monitor of receptor movement is needed.